Development of MRI methods for experimental disease models

Magnetic resonance imaging (MRI) is a powerful technique for the in vivo study of experimental disease models. The application of MRI to animal models requires the development of specialized methods which can provide insight into anatomy, function, physiology and specific pathology. This thesis rese...

Full description

Bibliographic Details
Main Author: Campbell-Washburn, A. E.
Published: University College London (University of London) 2012
Subjects:
610
Online Access:http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.625958
id ndltd-bl.uk-oai-ethos.bl.uk-625958
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-6259582015-12-03T03:25:01ZDevelopment of MRI methods for experimental disease modelsCampbell-Washburn, A. E.2012Magnetic resonance imaging (MRI) is a powerful technique for the in vivo study of experimental disease models. The application of MRI to animal models requires the development of specialized methods which can provide insight into anatomy, function, physiology and specific pathology. This thesis research focused around the development of MRI methods for imaging the mouse heart and other body organs. In this work, single slice arterial spin labelling (ASL) was implemented and optimized for the in vivo measurement of perfusion in the mouse heart. A fast ECG-gated Look-Locker sequence was used for T1 mapping with data logger recordings for the assessment of respiration corruption and additional prospective gating. A variability and repeatability study was performed to assess the applicability of the technique in vivo. This technique was then extended to have multi-slice capabilities through the implementation of a multi-slice cardiac T1 mapping sequence. In order to apply the multi-slice sequence in vivo, a new method of perfusion quantification was developed to compensate for the input function of the blood magnetization. Amyloidosis is a severe condition where amyloidotic fibrils of mis-folded proteins accumulate in the extracellular space. With the development of new therapies, there is an urgent need for sensitive imaging markers for the monitoring of amyloidosis. In this research, the extracellular volume fraction, as measured using equilibrium contrast MRI with primed infusions of gadolinium, was assessed as a marker for the detection of amyloidosis and for the monitoring of amyloid depletion during therapy. Finally, in order to remove spike noise in MRI data sets, a post-processing algorithm was implemented and validated for the removal of RF spikes in k-space Overall, this thesis research presents methodological developments of cardiac and body MRI for the in vivo study of experimental models of disease.610University College London (University of London)http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.625958http://discovery.ucl.ac.uk/1378548/Electronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic 610
spellingShingle 610
Campbell-Washburn, A. E.
Development of MRI methods for experimental disease models
description Magnetic resonance imaging (MRI) is a powerful technique for the in vivo study of experimental disease models. The application of MRI to animal models requires the development of specialized methods which can provide insight into anatomy, function, physiology and specific pathology. This thesis research focused around the development of MRI methods for imaging the mouse heart and other body organs. In this work, single slice arterial spin labelling (ASL) was implemented and optimized for the in vivo measurement of perfusion in the mouse heart. A fast ECG-gated Look-Locker sequence was used for T1 mapping with data logger recordings for the assessment of respiration corruption and additional prospective gating. A variability and repeatability study was performed to assess the applicability of the technique in vivo. This technique was then extended to have multi-slice capabilities through the implementation of a multi-slice cardiac T1 mapping sequence. In order to apply the multi-slice sequence in vivo, a new method of perfusion quantification was developed to compensate for the input function of the blood magnetization. Amyloidosis is a severe condition where amyloidotic fibrils of mis-folded proteins accumulate in the extracellular space. With the development of new therapies, there is an urgent need for sensitive imaging markers for the monitoring of amyloidosis. In this research, the extracellular volume fraction, as measured using equilibrium contrast MRI with primed infusions of gadolinium, was assessed as a marker for the detection of amyloidosis and for the monitoring of amyloid depletion during therapy. Finally, in order to remove spike noise in MRI data sets, a post-processing algorithm was implemented and validated for the removal of RF spikes in k-space Overall, this thesis research presents methodological developments of cardiac and body MRI for the in vivo study of experimental models of disease.
author Campbell-Washburn, A. E.
author_facet Campbell-Washburn, A. E.
author_sort Campbell-Washburn, A. E.
title Development of MRI methods for experimental disease models
title_short Development of MRI methods for experimental disease models
title_full Development of MRI methods for experimental disease models
title_fullStr Development of MRI methods for experimental disease models
title_full_unstemmed Development of MRI methods for experimental disease models
title_sort development of mri methods for experimental disease models
publisher University College London (University of London)
publishDate 2012
url http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.625958
work_keys_str_mv AT campbellwashburnae developmentofmrimethodsforexperimentaldiseasemodels
_version_ 1718140960737591296